vimarsana.com

Page 62 - நிறுவனம் ஆஃப் உயிரியல் ப்ராடக்ட்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China gives conditional approval to Sinopharm COVID vaccine

BEIJING (AP) China authorized its first homegrown COVID-19 vaccine for general use Thursday, adding another shot that could see wide use in poorer countries as the virus surges back around the globe. The Sinopharm vaccine had already been given to groups such as health care professionals and essential workers under emergency-use guidelines as part of China's program to inoculate 50 million people before the Lunar New Year holiday in February..

China Approves Public Use of Sinopharm Vaccine Against COVID-19 – Reports

China Approves Public Use of Sinopharm Vaccine Against COVID-19 – Reports © REUTERS / TINGSHU WANG Subscribe Sputnik International https://sputniknews.com/asia/202012311081616171-china-approves-public-use-of-sinopharm-vaccine-against-covid-19 reports/ BEIJING (Sputnik) – China’s National Medical Products Administration authorized on Thursday the public use of the Sinopharm vaccine against the coronavirus, the China Central Television reported. On Wednesday, Sinopharm’s subsidiary Beijing Institute of Biological Products said that the efficiency of its vaccine had exceeded 79 percent. The vaccine has already been approved by Bahrain and the United Arab Emirates. The scientists will reportedly continue to study the efficiency of the vaccine. © AP Photo / Zhang Yuwei In this April 11, 2020, photo released by Xinhua News Agency, a staff member tests samples of a potential COVID-19

China OKs first homegrown vaccine said to be 79 3% effective

China OKs first homegrown vaccine said to be 79 3% effective
lasvegassun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lasvegassun.com Daily Mail and Mail on Sunday newspapers.

China OKs First Homegrown Vaccine as COVID Surges Globally

CoronavirusWorld Thursday, December 31, 2020 at 5:29 am | ט ז טבת תשפ א BEIJING (AP) - Thursday, December 31, 2020 at 5:29 am | ט ז טבת תשפ א A staff member inspects syringes of COVID-19 inactivated vaccine products at a packaging plant of the Beijing Biological Products Institute Co., Ltd, a unit of state-owned Sinopharm, in Beijing. (Zhang Yuwei/Xinhua via AP, File) China has approved its first homegrown COVID-19 vaccine for general use, health regulators said Thursday, marking the addition of another vaccine in the global fight against a virus that is surging back in many places as winter sets in. The two-dose vaccine from state-owned Sinopharm is the first approved for general use in China. The go-ahead comes shortly after the country launched a program to vaccinate 50 million people before the Lunar New Year in February. It also comes one day after British regulators authorized AstraZeneca’s inexpensive and easy-to-handle vaccine.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.